Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,154
archived clinical trials in
Osteoarthritis (OA)

A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
GSK Investigational Site
1205
mi
from
Fresno, CA
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
1205
mi
from
Fresno, CA
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
GSK Investigational Site
1103
mi
from
Oldsmar, FL
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
1103
mi
from
Oldsmar, FL
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
GSK Investigational Site
1282
mi
from
West Palm Beach, FL
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
1282
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
GSK Investigational Site
611
mi
from
Chicago, IL
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
611
mi
from
Chicago, IL
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
GSK Investigational Site
32
mi
from
Wichita, KA
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
32
mi
from
Wichita, KA
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
GSK Investigational Site
1438
mi
from
Watertown, MA
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
1438
mi
from
Watertown, MA
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
GSK Investigational Site
1298
mi
from
Hartsdale, NY
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
1298
mi
from
Hartsdale, NY
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
GSK Investigational Site
749
mi
from
Dayton, OH
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
749
mi
from
Dayton, OH
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
GSK Investigational Site
978
mi
from
Smithfield, PA
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
978
mi
from
Smithfield, PA
Click here to add this to my saved trials
AP-007 Study to Evaluate Safety and Exploratory Efficacy of Three Intra-articular Injections of Ampion in the Knee of Adults With Pain Due to Osteoarthritis
A Prospective Phase I/II Study to Evaluate the Safety and Exploratory Efficacy of Three Intra-articular Injections of Ampion™ (4 ML) Administered Two Weeks Apart in Adults With Pain Due to Osteoarthritis of the Knee
Status: Enrolling
Updated:  5/4/2016
Vaughan Clift, Ampio Pharmaceuticals
399
mi
from
Englewood, CO
AP-007 Study to Evaluate Safety and Exploratory Efficacy of Three Intra-articular Injections of Ampion in the Knee of Adults With Pain Due to Osteoarthritis
A Prospective Phase I/II Study to Evaluate the Safety and Exploratory Efficacy of Three Intra-articular Injections of Ampion™ (4 ML) Administered Two Weeks Apart in Adults With Pain Due to Osteoarthritis of the Knee
Status: Enrolling
Updated: 5/4/2016
Vaughan Clift, Ampio Pharmaceuticals
399
mi
from
Englewood, CO
Click here to add this to my saved trials
Chronic Muscle Disuse in the Elderly
Muscle Disuse and Contractile Dysfunction in the Elderly
Status: Enrolling
Updated:  5/10/2016
University of Vermont and State Agricultural College
1356
mi
from
Burlington, VT
Chronic Muscle Disuse in the Elderly
Muscle Disuse and Contractile Dysfunction in the Elderly
Status: Enrolling
Updated: 5/10/2016
University of Vermont and State Agricultural College
1356
mi
from
Burlington, VT
Click here to add this to my saved trials
Total Knee Arthroplasty Functional Outcomes Study Research Design
Total Knee Arthroplasty Functional Outcomes Study Research Design
Status: Enrolling
Updated:  5/12/2016
Ochsner Clinic Foundation
694
mi
from
New Orleans, LA
Total Knee Arthroplasty Functional Outcomes Study Research Design
Total Knee Arthroplasty Functional Outcomes Study Research Design
Status: Enrolling
Updated: 5/12/2016
Ochsner Clinic Foundation
694
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated:  6/29/2016
Clinical Research Facility
1143
mi
from
San Diego, CA
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated: 6/29/2016
Clinical Research Facility
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated:  6/29/2016
Clinical Research Facility
1284
mi
from
West Palm Beach, FL
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated: 6/29/2016
Clinical Research Facility
1284
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated:  6/29/2016
Clinical Research Facility
788
mi
from
Marietta, GA
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated: 6/29/2016
Clinical Research Facility
788
mi
from
Marietta, GA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated:  6/29/2016
Clinical Research Facility
971
mi
from
Las Vegas, NV
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated: 6/29/2016
Clinical Research Facility
971
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated:  6/29/2016
Clinical Research Facility
1052
mi
from
Duncansville, PA
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated: 6/29/2016
Clinical Research Facility
1052
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated:  6/29/2016
Clinical Research Facility
27
mi
from
Wichita, KA
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated: 6/29/2016
Clinical Research Facility
27
mi
from
Wichita, KA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated:  6/29/2016
Clinical Research Facility
832
mi
from
Bay City, MI
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated: 6/29/2016
Clinical Research Facility
832
mi
from
Bay City, MI
Click here to add this to my saved trials
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated:  6/29/2016
Clinical Research Facility
1298
mi
from
Hartsdale, NY
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated: 6/29/2016
Clinical Research Facility
1298
mi
from
Hartsdale, NY
Click here to add this to my saved trials
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated:  6/29/2016
Clinical Research Facility
1424
mi
from
Providence, RI
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated: 6/29/2016
Clinical Research Facility
1424
mi
from
Providence, RI
Click here to add this to my saved trials
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated:  6/29/2016
Clinical Research Facility
1013
mi
from
Danville, VA
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated: 6/29/2016
Clinical Research Facility
1013
mi
from
Danville, VA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated:  6/29/2016
Clinical Research Facility
628
mi
from
Valparaiso, IN
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated: 6/29/2016
Clinical Research Facility
628
mi
from
Valparaiso, IN
Click here to add this to my saved trials
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated:  6/29/2016
Clinical Research Facility
719
mi
from
Chattanooga, TN
A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Status: Enrolling
Updated: 6/29/2016
Clinical Research Facility
719
mi
from
Chattanooga, TN
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 5
840
mi
from
Mesa, AZ
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 5
840
mi
from
Mesa, AZ
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 13
1155
mi
from
Anaheim, CA
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 13
1155
mi
from
Anaheim, CA
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 13
1155
mi
from
Anaheim, CA
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 13
1155
mi
from
Anaheim, CA
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 13
1155
mi
from
Anaheim, CA
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 13
1155
mi
from
Anaheim, CA
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 26
1184
mi
from
Canoga Park, CA
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 26
1184
mi
from
Canoga Park, CA
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 42
1141
mi
from
Carlsbad, CA
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 42
1141
mi
from
Carlsbad, CA
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 30
1274
mi
from
Carmichael, CA
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 30
1274
mi
from
Carmichael, CA
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 33
1163
mi
from
Cerritos, CA
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 33
1163
mi
from
Cerritos, CA
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 34
1186
mi
from
Dallas, CA
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 34
1186
mi
from
Dallas, CA
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 25
1130
mi
from
El Cajon, CA
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 25
1130
mi
from
El Cajon, CA
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 24
1134
mi
from
La Mesa, CA
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 24
1134
mi
from
La Mesa, CA
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 2
1161
mi
from
Pasadena, CA
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 2
1161
mi
from
Pasadena, CA
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 13
1132
mi
from
Rancho Cucamonga, CA
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 13
1132
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 27
1283
mi
from
Sacramento, CA
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 27
1283
mi
from
Sacramento, CA
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 10
1307
mi
from
Fort Lauderdale, FL
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 10
1307
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 41
1313
mi
from
Hialeah, FL
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 41
1313
mi
from
Hialeah, FL
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 3
1309
mi
from
Miami Lakes, FL
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 3
1309
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 1
1322
mi
from
Miami, FL
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 1
1322
mi
from
Miami, FL
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 1
1322
mi
from
Miami, FL
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 1
1322
mi
from
Miami, FL
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 1
1322
mi
from
Miami, FL
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 1
1322
mi
from
Miami, FL
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 1
1322
mi
from
Miami, FL
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 1
1322
mi
from
Miami, FL
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 1
1322
mi
from
Miami, FL
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 1
1322
mi
from
Miami, FL
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 11
1284
mi
from
West Palm Beach, FL
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 11
1284
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 11
1284
mi
from
West Palm Beach, FL
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 11
1284
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 8
613
mi
from
Evanston, IL
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 8
613
mi
from
Evanston, IL
Click here to add this to my saved trials
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated:  7/6/2016
Glenmark Investigational Site 43
568
mi
from
Newburgh, IN
To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee
Status: Enrolling
Updated: 7/6/2016
Glenmark Investigational Site 43
568
mi
from
Newburgh, IN
Click here to add this to my saved trials